Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
about
Tiotropium versus placebo for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisTiotropium versus placebo for chronic obstructive pulmonary diseaseLong-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled StudyAssociation of plasma adiponectin levels with cellular hydration state measured using bioelectrical impedance analysis in patients with COPD"Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database.A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study.Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.Year in review 2011: asthma, chronic obstructive pulmonary disease and airway biology.TIOtropium Safety and Performance In Respimat (TIOSPIR): Analysis of Asian cohort of COPD patients.Impact of mild exacerbation on COPD symptoms in a Japanese cohortA diagnostic approach and natural course of a patient with asthma-COPD overlap syndrome.Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.Breathing-swallowing discoordination is associated with frequent exacerbations of COPD.Similarities and differences between East and West in COPD.Survey to determine the efficacy and safety of guideline-based pharmacological therapy for chronic obstructive pulmonary disease patients not previously receiving maintenance treatment.Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.Asthma-like Features and Clinical Course of Chronic Obstructive Pulmonary Disease. An Analysis from the Hokkaido COPD Cohort Study.Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries
P2860
Q24194833-5A2B38AC-F7B2-4268-AB6C-B57E4C6277B0Q24197853-3970CBCA-72D7-4C74-ABB4-C94E94F1FD37Q24202175-B5110973-48F8-4DFE-8417-5918C076ECE6Q28546584-C6C84E9E-C8F4-4C2C-879E-736913C22E75Q36173154-15B71767-C82F-4712-8E28-159E7CECB51AQ36557724-2C3E3CB0-A669-4AAC-88BA-58EB31181BC6Q36826833-C0516736-DA71-409C-9A3B-7A62A9F9D0D8Q36908069-AF8C77D7-5400-4A82-ABC1-10A77C19CE13Q37177278-30553CE3-FFD5-4E35-AB7A-CFE2EBA7818BQ37344251-A0BFAE15-C865-4042-BAE7-03A9CAA56FB6Q37603590-2422D48B-2C7D-402E-8CDD-9E918B737671Q37973132-DAF6ACB5-8596-4C81-A185-E764BC4AEFA9Q37976115-FEDCECE4-3BEB-4AB5-9505-EF23001F6A94Q38411864-02B98583-EF61-4C4B-9320-62CEA5C6A312Q39646728-F410CA15-92B8-4EAF-9642-5C4FC747948AQ40133726-AD6CCD6A-1504-45D2-A291-B964707A58B4Q40902162-9D626F1F-0588-4BEB-90EE-1742675C319FQ41151952-9A24E6A6-CFAA-472D-B4AB-32B8F3BAFC69Q47653619-60762F90-4C33-4719-BF5A-D1B2F6C5F71BQ47984941-EA5D1F49-69C6-4DCD-A243-663269C832A3Q51171610-FA7B40B8-1663-4F03-B661-1CDA0192D5E0Q51310099-6BFF70D4-8097-46F4-A8F9-B157AE292765Q59126241-0626F7DB-2A9D-40BE-A5AF-4AE788AB471C
P2860
Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@en
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@nl
type
label
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@en
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@nl
prefLabel
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@en
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@nl
P2093
P2860
P1433
P1476
Efficacy of tiotropium in COPD ...... nalysis from the UPLIFT trial.
@en
P2093
Aziah Mahayiddin
Bartolome Celli
Dacheng Liu
Donald Tashkin
Han-Pin Kuo
Lenora Fernandez
Steven Kesten
Yoshinosuke Fukuchi
P2860
P304
P356
10.1111/J.1440-1843.2011.01982.X
P577
2011-07-01T00:00:00Z